Afficher la couverture 'Beta-Blocker Interruption or Continuation after Myocardial Infarction | Silvain, Johanne' en grand format
/5

0 avis

Beta-Blocker Interruption or Continuation after Myocardial Infarction

Archive ouverte

Silvain, Johanne | Cayla, Guillaume | Ferrari, Emile | Range, Grégoire | Puymirat, Etienne | Delarche, Nicolas | Guedeney, Paul | Cuisset, Thomas | Ivanes, Fabrice | Lhermusier, Thibault | Petroni, Thibault | Lemesle, Gilles | Bresoles, François | Labeque, Jean-Noël | Pommier, Thibaut | Dillinger, Jean-Guillaume | Leclercq, Florence | Boccara, Franck | Lim, Pascal | Besseyre Des Horts, Timothée | Fourme, Thierry | Jourda, François | Furber, Alain | Lattuca, Benoit | Redjimi, Nassim | Thuaire, Christophe | Deharo, Pierre | Procopi, Niki | Dumaine, Raphaelle | Slama, Michel | Payot, Laurent | El Kasty, Mohamad | Aacha, Karim | Diallo, Abdourahmane | Vicaut, Eric | Montalescot, Gilles

Edité par CCSD ; Massachusetts Medical Society -

International audience. The appropriate duration of treatment with beta-blocker drugs after a myocardial infarction is unknown. Data are needed on the safety and efficacy of the interruption of long-term beta-blocker treatment to reduce side effects and improve quality of life in patients with a history of uncomplicated myocardial infarction.

Consulter en ligne

Suggestions

Du même auteur

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Archive ouverte | Guedeney, Paul | CCSD

International audience

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Archive ouverte | Silvain, Johanne | CCSD

International audience. Background: Percutaneous coronary intervention (PCI)-related myonecrosis is frequent and can affect the long-term prognosis of patients. To our knowledge, ticagrelor has not been evaluated in...

Twice-a-day administration of aspirin in patients with diabetes mellitus or aspirin resistance after acute coronary syndrome: Rationale and design of the randomized ANDAMAN trial

Archive ouverte | Dillinger, Jean-Guillaume | CCSD

International audience. BACKGROUND: Patients with diabetes mellitus (DM) or aspirin resistance are exposed to recurrent atherothrombotic events after acute coronary syndrome (ACS). Aspirin once-daily can allow the r...

Chargement des enrichissements...